Clinical trial
A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan…
NCT00308347 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00308347 |
|---|---|
| Title | A Research Study to Evaluate the Renal (Kidney) Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes (0954-147)(COMPLETED) |
| Official title | A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Renal Protective Effects of Losartan in Patients With Non-insulin Dependent Diabetes Mellitus and Nephropathy |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Nephropathy |
| Intervention type | Drug |
| Interventions | MK0954, losartan / Duration of Treatment: mean 3.4 years, Placebo / Duration of Treatment: mean 3.4 years |
| Enrollment | 1,513 |
| Start date | May 1, 1996 |
| Primary completion | Feb 1, 2001 |
| Completion | Apr 1, 2001 |
| First posted | Mar 29, 2006 |
| Last update posted | Feb 15, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: